Bioiberica Animal Nutrition will present Nucleoforce Aqua™ at the Aquaculture Europe 2019 congress, held in Berlin, Germany on 7-10 October 2019 at the ESTREL Congress Center.
Nucleoforce Aqua™ is a balanced concentrate combining free nucleotides and active precursors obtained from yeast. With a 30% concentration of available nucleotides, the unique composition of Nucleoforce Aqua™ is designed to meet precisely and specifically the needs of fish, promoting the optimum development of their immune and digestive systems. Thanks to its exceptional features, it reduces the inflammatory response caused by diets containing a high percentage of plant raw materials, thus improving the digestibility of diets and the animals’ intestinal health.
At Berlin, Bioiberica will join ACUIPLUS, a cluster supporting and promoting success strategies for a group of aquiculture sector firms, both a the national and international levels (booth #85, 95 and 96).
“OUT FUTURE: Growing from water” is the motto of Aquaculture Europe 2019. The future of healthy and sustainably produced food lies in aquaculture, and truly unlocking this potential requires innovative ways to support the aquaculture economy, generation of new business models and support of start-ups, as well as innovative and eco-friendly products with high added value. Aquaculture Europe 2019 covers the entire aquiculture sector, featuring a wide range of activities including oral presentations, posters, and international fair, industry forums and students’ workshops.
Bioiberica Animal Nutrition specializes in the development, manufacture and marketing of products for the improvement of immune and gut health in the early stages of development of farm animals, aquiculture species, and pets. Our aim is to preserve the animals’ healthcare from the damaging effects of stress, and help farmers to optimize the sustainability and profitability of their businesses.
The distribution of Bioiberica's Palbio™ range through Mill Tech Co., Inc. in South Korea has been approved after fulfilling stringent regulatory requirements.